Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptions

Sorrento Therapeutics, Inc. News

Cramer's Mad Money Recap: Walmart, Amazon, Apple

As COVID re-emerges, Jim Cramer says it's time to look at companies that flourish in an economy that might get worse before it gets better.

Cramer's Mad Money Recap: Shopify, Etsy, Square

Jim Cramer says small business is fueling our economy and investors should look to the companies supporting small business.

5 Top Stock Gainers for Monday: Corsair, MicroStrategy, Torchlight

Corsair Gaming, Riot Blockchain, Torchlight Energy Resources, MicroStrategy and Sorrento Therapeutics are five top stock gainers for Monday.

Cramer's Mad Money Recap: Skyworks, AEP, Nucor

Game plan for a heavy round of earnings next week.

Sorrento Up on Request for Emergency Authorization for Covid Test

Sorrento Therapeutics jumped after the biopharma said it applied for FDA emergency-use authorization for its covid-19 test.

Breaking News

Gap Stock Plummets On Wider Q1 Loss, Grim Profit Outlook As Shoppers Shun Casual Apparel

"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.

Big Lots Stock Crumbles After Surprise Q1 Loss As Inflation, Gas Price Surge Bites Spending

"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.